FDA Inspection 969078 — KUPI Reproductive Endocrinology & Infertility Lab
The FDA completed an inspection of KUPI Reproductive Endocrinology & Infertility Lab on April 29, 2016 in Overland Park, KS. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- April 29, 2016
- Fiscal Year
- 2016
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Overland Park, KS (United States)